Back to News
Market Impact: 0.35
Moderna (MRNA) Q3 Earnings and Revenues Top Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany FundamentalsAnalyst Estimates
Moderna reported quarterly earnings of $0.38 per share, versus the Zacks Consensus Estimate of a loss of $1.10 per share. This compares with a loss of $0.51 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
MRNA0.70
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- Stocks making the biggest moves midday: Nvidia, Moderna, IonQ, Airbnb, Firefly Aerospace & more
- While biotech bets swing on trial data, this dividend payer gained 72% since 2024
- 5 Things Investors Need to Know About Friday's Markets
- Our top 10 things to watch in the stock market Friday
- Stocks making the biggest moves premarket: Moderna, Airbnb, Cloudflare, Affirm & more